NCT02544373View on ClinicalTrials.gov

CPAP to Treat Cognitive Dysfunction in MS

NACompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

November 12, 2015

Primary Completion Date

June 25, 2021

Study Completion Date

June 25, 2021

Conditions
Multiple Sclerosis
Interventions
DEVICE

PAP therapy

Positive airway pressure treatment for obstructive sleep apnea

Trial Locations (1)

48109

University of Michigan Medical Center, Ann Arbor

All Listed Sponsors
collaborator

National Multiple Sclerosis Society

OTHER

lead

University of Michigan

OTHER

NCT02544373 - CPAP to Treat Cognitive Dysfunction in MS | Biotech Hunter | Biotech Hunter